Gainers
- Moleculin Biotech Inc (NASDAQ:MBRX) shares rose 40.7 percent to $3.39 in the pre-market trading session after the company disclosed that it has received the FDA approval for its Annamycin IND.
- Ascena Retail Group Inc (NASDAQ:ASNA) rose 16.6 percent to $2.53 in pre-market trading after the company posted stronger-than-expected results for its fourth quarter.
- Chromadex Corp (NASDAQ:CDXC) rose 16 percent to $5.00 in pre-market trading after the company reported top-line results from its second human clinical trial.
- Greenhill & Co., Inc. (NYSE:GHL) shares rose 13.9 percent to $16.40 in pre-market trading after the company disclosed outline of recap plan and share repurchase.
- Social Reality Inc (NASDAQ:SRAX) shares rose 10.2 percent to $2.70 in pre-market trading after surging 50.31 percent on Monday.
- Vascular Biogenics Ltd (NASDAQ:VBLT) rose 9.3 percent to $7.10 in pre-market trading after gaining 4.84 percent on Monday.
- Apollo Endosurgery Inc (NASDAQ:APEN) rose 7.7 percent to $4.90 in pre-market trading after falling 0.87 percent on Monday.
- ProQR Therapeutics NV (NASDAQ:PRQR) rose 7 percent to $6.90 in pre-market trading after the company disclosed 'positive' top-line data from Phase 1b study of QR-010.
- Izea Inc (NASDAQ:IZEA) rose 6.8 percent to $5.18 in pre-market trading after jumping 51.56 percent on Monday.
- Akebia Therapeutics Inc (NASDAQ:AKBA) rose 5.1 percent to $18.80 in pre-market trading. Akebia Therapeutics disclosed that statistically significant improvements in the primary endpoint were made in its Phase 2 study of Vadadustat.
- Helios and Matheson Analytics Inc (NASDAQ:HMNY) rose 4.6 percent to $8.68 in pre-market trading after surging 19.08 percent on Monday.
- Red Hat Inc (NYSE:RHT) rose 4.3 percent to $110.26 in pre-market trading after the company reported better-than-expected results for its second quarter and raised its guidance for the year.
- Kitov Pharmaceuticals Holdings Ltd (ADR) (NASDAQ:KTOV) shares rose 3.7 percent to $2.22 in pre-market trading after climbing 12.63 percent on Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- Axovant Sciences Ltd (NASDAQ:AXON) shares fell 69.7 percent to $7.36 after the company disclosed that Phase 3 MINDSET clinical trial did not meet its co-primary efficacy endpoints.
- Genocea Biosciences Inc (NASDAQ:GNCA) fell 55.2 percent to $2.39 in pre-market trading after the company reported strategic shift to immuno-oncology and development of neoantigen cancer vaccines. The company also announced plans to explore strategic alternatives for GEN-003 and lower staff by 40 percent.
- Kadmon Holdings Inc (NASDAQ:KDMN) fell 21.1 percent to $2.99 in pre-market trading as the company reported mixed shelf offering.
- QEP Resources Inc (NYSE:QEP) shares fell 7.1 percent to $8.25 in pre-market trading after the company reported the closing of Pinedale asset sale and lowered its FY17 production outlook.
- TherapeuticsMD Inc (NYSE:TXMD) shares fell 6.8 percent to $5.65 in pre-market trading. TherapeuticsMD priced its 12.4 million share offering at $5.65 per share.
- Sabra Health Care REIT Inc (NASDAQ:SBRA) fell 6.1 percent to $20.98 in pre-market trading. Sabra Health Care REIT priced an underwritten public offering of 16,000,000 shares at $21.00 per share.
- Aradigm Corporation (NASDAQ:ARDM) shares fell 5.1 percent to $3.19 in pre-market trading after climbing 32.81 percent on Monday.
- Cheesecake Factory Inc (NASDAQ:CAKE) fell 4.6 percent to $39.70 in pre-market trading. Wedbush downgraded Cheesecake Factory from Outperform to Neutral.
- Darden Restaurants, Inc. (NYSE:DRI) shares fell 3.8 percent to $80.02 in pre-market trading. Darden posted in-line quarterly earnings.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.